Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled trial of anakinra plus corticosteroids in giant cell arteritis
2015-005804-27Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Jan 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in giant cell arteritis (GCA) comparing Anakinra + prednisone with Placebo + prednisone (2 arms). Primary endpoint: Relapse rate at week 26. Started Jan 2016; status: completed.
02
Drugs
anakinra
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on 2015-005804-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005804-27.